Scinai Immunotherapeutics Ltd.
SCNI Nasdaq
SEC CIK 1611747
Follow Scinai Immunotherapeutics Ltd.
Weekly email: filings, results
EPS, diluted
-
Source: SEC XBRL filings · latest filing
Show the numbers
| Year | Net income |
|---|---|
| FY25 | −$8.3M |
| FY24 | $4.8M |
| FY23 | - |
| FY22 | - |
| FY21 | −$8.2M |
| FY20 | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$6.1M |
| FY24 | −$6.3M |
| FY23 | −$10M |
| FY22 | −$8.1M |
| FY21 | −$7.6M |
| FY20 | - |